Wednesday - October 24, 2018 2018 winners of the Global Ophthalmology Award Programme announced Out of more than 100 submissions, 12 ophthalmology researchers and clinicians will receive awards of up to $50,000 to support their innovative research as part of the 2018 Global Ophthalmology Awards ProgrammeJasmina Kapetanovic from the University of Oxford receives Fellowship Award more
Friday - September 28, 2018 Protecting patient access to licensed and NICE recommended treatments for wet age-related macular degeneration Following the judicial review judgment on 21 September, the High Court has decided that in certain circumstances it is lawful to offer patients bevacizumab injections for the treatment of wet age-related macular degeneration (wet AMD) in preference to approved licensed treatments, even though bevacizumab is not manufactured or licensed for use in the eye. more
Friday - September 21, 2018 Protecting patient access to licensed and NICE recommended treatments for wet age-related macular degeneration Following a judicial review, the High Court has decided that, in certain circumstances, it is potentially lawful to offer patients bevacizumab injections for the treatment of wet age-related macular degeneration (wet AMD) in preference to approved licensed treatments, even though bevacizumab is not manufactured or licensed for use in the eye. more
Advancing Together: Bayer to Acquire Monsanto The acquisition realizes the joint vision of integrated agricultural offering delivering superior solutions for growers and creates an innovation powerhouse for the next generation of farming. more
